|
| Exchange Received Time 09/11/2018 12:41:02 Exchange Disseminated Time 09/11/2018 12:41:08 Time Taken 00:00:06 | Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to intimate that a conference call for the Indian and overseas analysts has been arranged by our management to discuss the Company's financial results for Quarter / Half Year ended September 30, 2018, on Monday, November 12, 2018 at 2.30 P.M. local time. Dr. A. Velumani, Chairman & Managing Director, Mr. A. Sundararaju, Executive Director & CFO, Mr. Sachin Salvi, General Manager- Finance, and Mr. Anand Velumani, Director, Nueclear Healthcare Limited, will represent the Company. Dial-in details are given in the copy of enclosed Invite of M/s. Prabhudas Lilladher, who are organizing the con-call.
|
|
|